Regorafenib: lights and shadows of antiangiogenic therapies in gastric cancer

Transl Gastroenterol Hepatol. 2017 Feb 23:2:11. doi: 10.21037/tgh.2017.02.01. eCollection 2017.
No abstract available

Publication types

  • Comment